Outcome of Board Meeting Approved In-Principally, the proposal of amalgamation of Ind-Swift Limited, a group company with Ind-Swift Laboratories Limited. The Audit Committee and Board of Directors of the company will consider and approve the draft Scheme of Arrangement, Report on Valuation of Shares and Fairness Opinion Report and such other incidental documents in their forthcoming meetings. Intimation of the same will be circulated in due course. Disclosure under Regulation 30 regarding Scheme of arrangement for Amalgamation The Board of Directors in their meeting held today i.e. 25.09.2023 have inter-alia considered and approved the Scheme of Arrangement for Amalgamation. (As Per BSE Announcement Dated on 25/09/2023) The Board of Directors of the Company, in their meeting held on March 8, 2024 have considered and approved certain modifications in the Scheme of Arrangement for Amalgamation of Ind-Swift Limited ('Transferor Company'/'the Company') with Ind-Swift Laboratories Limited ('Transferee Company') ('Scheme') which was originally approved by the Board on September 25, 2023 on a going concern basis, under the provisions of section 230-232 of the Companies Act, 2013 and the Rules made thereunder. Please refer attached PDF. (As Per BSE Announcement Dated on 08/03/2024) Update on merger of the company with Ind Swift Laboratories Limited (Group Company) (As Per BSE Announcement Dated on 10/04/2024) Outcome of Board meeting dated May 18, 2024 (As Per BSE Announcement Dated on 18.05.2024) Receipt of the order passed by the Hon''ble NCLT, Chandigarh Bench on 03/01/2025 pursuant to the first motion petition filed by the Company. (As Per BSE Announcement Dated on: 04/01/2025) Intimation regarding Hearing of Second Motion Petition and next date of hearing (As Per BSE Announcement Dated on :15.05.2025) Updates on 2nd Motion Petition for approval of Scheme of Arrangement (As Per BSE Announcement Dated on: 29/05/2025) We hereby inform that Hon''ble NCLT, Chandigarh bench has approved the Scheme of Arrangement for the Amalgamation of Ind Swift Limited with Ind Swift Laboratories Limited vide order dated July 17, 2025. (As per BSE Announcement Dated on 17/07/2025) Please refer to enclosed PDF (As Per BSE Announcement Dated on: 28.07.2025) Please refer to attached pdf (As Per BSE Announcement Dated on: 29/07/2025) Trading members of the Exchange are hereby informed that, pursuant to the Scheme of Arrangement (for Amalgamation) as approved by the Hon'ble National Company Law Tribunal (NCLT), CHANDIGARH Bench, Providing for the Merger of Ind-Swift Limited ('Transferor Company') INTO Ind-Swift Laboratories Limited ('Transferee Company'), Ind-Swift limited has informed the Record Date fixed for the purpose of Amalgamation and to determine the entitlement of shareholders of Ind-Swift limited to the Equity Shares of Ind-Swift Laboratories Limited. Trading Members are advised not to deal in the Equity Shares of Ind-Swift limited with effect from the under mentioned date :- COMPANY NAME CODE Ind-Swift limited (524652) RECORD DATE 14/08/2025 PURPOSE As per Scheme of Arrangement (For Amalgamation) approved by the Hon'ble National Company Law Tribunal, Chandigarh Bench; Upon coming into effect of the Scheme of Amalgamation between Ind-Swift limited (Transferor Company) and Ind-Swift Laboratories Limited (Transferee Company) and in consideration of the Amalgamation of Ind-Swift limited INTO Ind-Swift Laboratories Limited; Ind-Swift Laboratories Limited shall Issue and allot Equity Shares to the Shareholders of Ind-Swift limited in the following proportion: 15 Equity shares of the Face Value of Rs. 10/- per share of Ind-Swift Laboratories Limited to be issued for every 100 Equity shares of the Face Value of Rs.2/- per share held by the shareholders in Ind-Swift limited ; NO DEALINGS FROM W.E.F. 14/08/2025 DR-695/2025-2026 Trading Members are requested to take note of the above. (As Per BSE Notice Dated on 11.08.2025) Allotment of 81,24,698 equity shares by the company pursuant to Scheme of Arrangement for the Amalgamation of Ind Swift Limited with Ind Swift Laboratories Limited. (As Per BSE Announcement Dated on:25.08.2025) Intimation Of Trading Approval Obtained From Stock Exchanges For 81,24,698 Equity Shares Of ?10/- Each Issued Pursuant To The Approved Scheme Of Amalgamation (As per BSE Announcement dated on: 05.12.2025)